Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Status:
RECRUITING

Trial end date:
2025-12-01

Target enrollment:

Participant gender:

This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.

PHASE3

Vanda Pharmaceuticals